Oncolytic Virus Therapy Market Share, Forecast, Overview and Key...

Oncolytic Virus Therapy Market Share, Forecast, Overview and Key Companies Analysis by 2028

175

Posted 2021-07-21 10:03:10

The global oncolytic virus therapy market size is expected to reach USD 866.1 Million at a steady CAGR of 23.9% in 2028, according to latest analysis by Emergen Research. Steady growth of oncolytic virus therapy market can be attributed to rising cancer incidence globally. The report provides detailed insights into Oncolytic Virus Therapy market trends, industry trends, consumer trends, market size, market share, market revenue growth, and forecast, along with ranging impact of each factor and driver. It also provides analysis of various factors expected to restrain or limit potential growth in market size over the forecast period, 2020–2028. The report includes profiles of major players in the Oncolytic Virus Therapy market, strategies being employed, mergers, acquisitions, recent developments, agreements, contracts, new product development and launches, segment revenue, investment details as well as financials.

Download FREE Sample PDF Copy (Customized Sample PDF File delivered as per your specific requirement)@ https://www.emergenresearch.com/request-sample/541

The steady Oncolytic Virus Therapy market share growth can be attributed to a variety of factors and trends in the global Oncolytic Virus Therapy market currently. Global Oncolytic Virus Therapy market revenue growth is supported to a significant extent due to rising focus by major players on product/service expansion into new and untapped domestic markets and rising competition in the market. These factors are expected to drive incline in regional Oncolytic Virus Therapy market share growth over the forecast period. Oncolytic virus therapy (a type of immunotherapy) uses engineered viruses to destroy cancer cells without affecting healthy cells in the human body. Once a cancer cell is destroyed, it releases cancer antigens that trigger immune responses to destroy other tumor cells in the body. In addition, rapidly rising demand and deployment in respective sectors/industries in major and developing countries is supporting growth in terms of Oncolytic Virus Therapy market share contribution of these countries. In addition, Oncolytic Virus Therapy market share contribution is expected to continue to incline steadily over the forecast period due to favorable government policies, advancements in technology, and steady economic growth across various regions and countries.

Top key vendors in Oncolytic Virus Therapy Market include are:

Oncolytics Biotech Inc., Lokon Pharma AB, PsiOxus Therapeutics, Sorrento Therapeutics Inc., CG Oncology Inc., ORYX GmbH & Co. KG, VCNBiosciences, DNAtrix, Targovax, and SillaJen Inc.

Emergen Research has segmented the global oncolytic virus therapy market on the basis of type, application, end-use, and region:

Type Outlook (Revenue, USD Million; 2021–2028)
- Monoclonal Antibodies
- Checkpoint Inhibitors
- Cancer Vaccines
- Immunomodulators

Application Outlook (Revenue, USD Million; 2021–2028)
- Melanoma
- Lung Cancer
- Breast Cancer
- Others

End-Use Outlook (Revenue, USD Million; 2021–2028)
- Hospitals
- Clinics
- Research Institutes
- Others

Regional Outlook (Revenue, USD Million; 2021–2028)
- North America
  1. U.S.
  2. Canada
  3. Mexico
- Europe
  1. Germany
  2. U.K.
  3. France
  4. Italy
  5. Spain
  6. BENELUX
  7. Rest of Europe
- Asia Pacific
  1. China
  2. Japan
  3. South Korea
  4. Rest of APAC
- Latin America
  1. Brazil
  2. Rest of LATAM
- Middle East & Africa
  1. Saudi Arabia
  2. UAE
  3. South Africa
  4. Rest of MEA

Access the Entire Report packed with TOC, Tables and Figures and Outline of Prominent Companies@ https://www.emergenresearch.com/industry-report/oncolytic-virus-therapy-market

In terms of Oncolytic Virus Therapy market share and revenue contribution to the global Oncolytic Virus Therapy market, North America is expected to maintain its dominance over other regional markets over the forecast period. Presence of major companies in countries in the region is a key factor supporting rapid increase in Oncolytic Virus Therapy market share.

Incorporated with Info-graphics, charts, 70 tables and 85 figures, this 250-page research report “Oncolytic Virus Therapy Market Size, Type, Application, End-Use Industry, Regional Outlook, Competitive Strategies and Forecasts, 2020 - 2027” is based on a complete research of the entire Global market and covering all its sub-segments through comprehensively thorough classifications. Insightful analysis and assessment are created from superior primary and secondary information sources with data and information derived from industry specialists across the value chain.

Region wise performance of the Oncolytic Virus Therapy industry

Asia Pacific market share contribution to the global Oncolytic Virus Therapy market is expected to continue to register comparatively faster growth rate than other regional markets between 2020 and 2028. Rapid growth rate of China and India Oncolytic Virus Therapy market share contribution can be attributed to increasing population and disposable income, and steady economic growth, and the trend is expected to continue going ahead.

Steady increase in Europe Oncolytic Virus Therapy market share growth is primarily supported by continuous developments in major countries in the region. Robust focus on research and development initiatives by major firms in countries in the region is also expected to continue to support market share growth of the Europe Oncolytic Virus Therapy market going ahead.

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering:

United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:

North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa

We can customize our reports for our customers, for instance, we can add or remove manufacturers, applications or product types, whatever you need in the report. Ask for it by contacting us@ https://www.emergenresearch.com/request-for-customization/541

The research provides answers to the following key questions:

What will be the growth rate and the market size of the Oncolytic Virus Therapy industry for the forecast period 2020-2027?
What are the major driving forces expected to impact the development of the Oncolytic Virus Therapy market across different regions?
Who are the major driving forces expected to decide the fate of the Oncolytic Virus Therapy industry worldwide?
Who are the prominent market players making a mark in the Oncolytic Virus Therapy market with their winning strategies?
Which Oncolytic Virus Therapy industry trends are likely to shape the future of the industry during the forecast period 2020-2027?
What are the key barriers and threats believed to hinder the development of the industry?
What are the future opportunities in the Oncolytic Virus Therapy market?

Table of Content

Chapter 1. Methodology & Sources

1.1. Oncolytic Virus Therapy Market Definition

1.2. Research Scope

1.3. Methodology

1.4. Research Sources

1.4.1. Primary

1.4.2. Secondary

1.4.3. Paid Sources

1.5. Oncolytic Virus Therapy Market Estimation Technique

Chapter 2. Executive Summary

2.1. Summary Snapshot, 2021-2028